Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project

BACKGROUND: Concerns about hyperkalemia limit the use of angiotensin‐converting enzyme inhibitors (ACE‐I) and angiotensin receptor blockers (ARBs), but guidelines conflict regarding potassium‐monitoring protocols. We quantified hyperkalemia monitoring and risks after ACE‐I/ARB initiation and develop...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Heart Assoc
Egile Nagusiak: Bandak, Ghassan, Sang, Yingying, Gasparini, Alessandro, Chang, Alex R., Ballew, Shoshana H., Evans, Marie, Arnlov, Johan, Lund, Lars H., Inker, Lesley A., Coresh, Josef, Carrero, Juan‐Jesus, Grams, Morgan E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586281/
https://ncbi.nlm.nih.gov/pubmed/28724651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.005428
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak